3-MeO-PCMo Stats & Data

• Potency is far lower than 3‑MeO‑PCP, with many reports placing active oral and insufflated ranges in the 100–200+ mg area; always confirm identity with reagent or lab testing and start with a micro‑allergy test (1–3 mg). • Onset can lag 30–60 minutes orally; avoid redosing for at least 2 hours to prevent accidental stacking and unexpectedly strong intoxication. • Maintain a safe environment: dissociatives can impair balance and judgment while leaving users ambulatory; falls, wandering, and risk-taking behavior are documented with related analogues. • Nasal use: crystals are reported as poorly water‑soluble; insufflation may be inefficient and irritating—consider oral administration if choosing to proceed. • Hydration and bladder care matter: chronic/high‑frequency use of dissociatives has been linked to urinary tract symptoms (best practice is to limit frequency and maintain hydration). • Strong CNS depressant combinations (alcohol, GHB/GBL, opioids) markedly increase risks of unconsciousness, aspiration, and respiratory compromise—avoid these mixes. • If someone becomes severely confused, agitated, or unresponsive, seek medical care; supportive management, temperature control, and benzodiazepines for agitation are commonly used in clinical settings. • Tolerance builds quickly across the dissociative class; spacing sessions by several weeks reduces risk of escalation and adverse effects. • Due to extremely limited formal data and frequent mislabeling in the unregulated market, treat all material with caution; use drug checking services where available and avoid driving or hazardous activities for at least 12–24 hours after significant dosing.